Albert Bourla appears before the Senate Committee on Finance for a hearing on prescription drug pricing on Capitol Hill in Washington, DC, February 26, 2019. Chris Kleponis for CNP via AP Images
Pfizer CEO Albert Bourla is back in the M&A game, but why is he paying $11.4B for Array?
Pfizer $PFE has cut short its time on the sidelines of biopharma M&A.
Monday morning the pharma giant unveiled an $11.4 billion deal to acquire …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.